persmedРоссийский журнал персонализированной медициныRussian Journal for Personalized Medicine2782-38062782-3814ФОНД АЛМАЗОВА10.18705/2782-3806-2022-2-4-6-13persmed-64Research ArticleОБЗОРЫREVIEWERSОбновленная классификация первичных опухолей центральной нервной системы как основа персонализированного подхода к терапии пациентовUpdated classification of tumors of the central nervous system as the basis for individual patient therapyЗреловА. А.ZrelovA. A.

Зрелов Андрей Андреевич, кандидат медицинских наук, старший научный сотрудник НИЛ нейроонкологии, врач-нейрохирург 4-го нейрохирургического отделения

Санкт-Петербург 

Zrelov Andrei A., PhD (medicine), Senior Researcher, neurooncology laboratory, neurosurgeon

Saint Petersburg

НечаеваА. С.NechaevaN. E.

Нечаева Анастасия Сергеевна, врач-нейрохирург РНХИ им. проф. А. Л. Поленова — филиала ФГБУ «НМИЦ им. В. А. Алмазова» Минздрава России; аспирант 2-го года обучения по направлению «клиническая медицина» в Институте медицинского образования ФГБУ «НМИЦ им. В. А. Алмазова» Минздрава России; младший научный сотрудник НИО трансляционной онкологии Научно-исследовательского центра персонализированной онкологии НЦМУ «Центр персонализированной медицины»

ул. Маяковского, д. 12, Санкт-Петербург, 191014

Nechaeva Anastasia S., neurosurgeon, Polenov Neurosurgical Research Institute, postgraduate student of the 2nd year of study in the field of “clinical medicine” at the Institute for Medical Education, Almazov National Medical Research Centre; junior researcher of the Research Department of Translational Oncology of the Research Center for Personalized Oncology of the World-Class Research Centre for Personalized Medicine

Mayakovsky str., 12, Saint Petersburg, 1910141

nechaeva_as@almazovcentre.ruВоиновН. Е.VoinovN. E.

Воинов Никита Евгеньевич, врач-нейрохирург РНХИ им. проф. А. Л. Поленова  — филиала ФГБУ «НМИЦ им. В. А. Алмазова» Минздрава России; аспирант 2-го года обучения по  направлению «клиническая медицина» в  Институте медицинского образования ФГБУ «НМИЦ им. В. А. Алмазова» Минздрава России; специалист по научно-аналитической работе НЦМУ «Центр персонализированной медицины»

Санкт-Петербург

Voinov Nikita E., neurosurgeon, Polenov Neurosurgical Research Institute, postgraduate student of the 2nd year of study in the field of “clinical medicine” at the Institute for Medical Education, Almazov National Medical Research Centre; specialist in scientific and analytical work of the Research Center for Personalized Oncology of the World-Class Research Centre for Personalized Medicine

Saint Petersburg

Российский научно-исследовательский нейрохирургический институт имени профессора А. Л. Поленова» — филиал Федерального государственного бюджетного учреждения «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской ФедерацииРоссияPolenov Neurosurgical Research Institute, branch of the Almazov National Medical Research CentreRussian FederationРоссийский научно-исследовательский нейрохирургический институт имени профессора А. Л. Поленова» — филиал Федерального государственного бюджетного учреждения «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации; Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации, Научный центр мирового уровня «Центр персонализированной медицины»РоссияPolenov Neurosurgical Research Institute, branch of the Almazov National Medical Research Centre; World-Class Research Centre for Personalized MedicineRussian Federation20221609202224613Copyright © Зрелов А.А., Нечаева А.С., Воинов Н.Е., 20222022Зрелов А.А., Нечаева А.С., Воинов Н.Е.Zrelov A.A., Nechaeva N.E., Voinov N.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://persmed.elpub.ru/jour/article/view/64

Данная статья посвящена изменениям в последней, 5-й, редакции (2021 г.) Классификации Всемирной организации здравоохранения (ВОЗ) первичных опухолей центральной нервной системы (ЦНС), которые могут оказать влияние на клиническую практику в нейроонкологии. В литературном обзоре рассмотрен современный гибридный гистогенетический подход к таксономии и номенклатуре первичных опухолей ЦНС. Отмеченные особенности 5-й редакции классификации важны патологоанатомам и специалистам в области нейроонкологии. 

This article focuses on the latest edition of the World Health Organization (WHO) classification of primary tumors of the central nervous system (CNS), which was released in 2021, and the changes in it that may have an impact on clinical practice in neurooncology. The literature review considers a modern hybrid histo-molecular approach to the taxonomy and nomenclature of primary CNS tumors. The considered aspects of the 5th edition of the classification are necessary for pathologists and specialists in the field of neurooncology.

 

Всемирная организация здравоохраненияклассификациямолекулярное профилированиенейроонкологияопухоль головного мозгацентральная нервная системаbrain tumorcentral nervous systemclassificationmolecular profilingneurooncologyWorld Health OrganizationReferencesКуканов К.К., Тастанбеков М.М., Олюшин В.Е. и др. Менингиомы большого затылочного отверстия: результаты хирургического и радиохирургического лечения. Российский нейрохирургический журнал им. профессора А. Л. Поленова. 2016;8(4):26–35.Kukanov KK, Tastanbekov MM, Olyushin VE, et al. Meningiomas of the foramen magnum: results of surgical and radiosurgical treatment. Russian neurosurgical journal. Professor A. L. Polenov. 2016;8(4):26–35. In RussianОлюшин В.Е., Тастанбеков М.М., Сафаров Б.И. и др. Редкое наблюдение хориоидпапилломы мостомозжечкового угла. Описание случая и краткий обзор литературы. Российский нейрохирургический журнал им. профессора А. Л. Поленова. 2014;6(2):85–90.Olyushin VE, Tastanbekov MM, Safarov BI, et al. A rare observation of a choroid papilloma of the cerebellopontine angle. Description of the case and a brief review of the literature. Russian neurosurgical journal. Professor A. L. Polenov. 2014;6(2):85–90. In RussianХачатрян В.А., Улитин А.Ю., Самочерных К.А. и др. Медуллобластома (обзор литературы). Часть 1. Эпидемиология. Патоморфология. Диагностика. Нейрохирургия и неврология детского возраста. 2013;4(38):59–70.Khachatryan VA, Ulitin AYu, Samochernykh KA, et al. Medulloblastoma (literature review). Part 1. Epidemiology. Pathomorphology. Diagnostics. Neurosurgery and neurology of childhood. 2013;4(38):59–70. In RussianWHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021, WHO classification of tumours series, 5th ed.; vol. 6. https://tumourclassification.iarc.who.int/chapters/45.WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021, WHO classification of tumours series, 5th ed.; vol. 6. https://tumourclassification.iarc.who.int/chapters/45.Bonneville-Levard A, Frappaz D, Tredan O, et al. Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial. Med Oncol. 2021 Nov 5;39(1):4. DOI: 10.1007/s12032-021-01536-4.Bonneville-Levard A, Frappaz D, Tredan O, et al. Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial. Med Oncol. 2021 Nov 5;39(1):4. DOI: 10.1007/s12032-021-01536-4.Campanella R, Guarnaccia L, Caroli M, et al. Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department. J Neurol Sci. 2020 Oct 15;417:117083. DOI: 10.1016/j.jns.2020.117083.Campanella R, Guarnaccia L, Caroli M, et al. Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department. J Neurol Sci. 2020 Oct 15;417:117083. DOI: 10.1016/j.jns.2020.117083.Cavalli FMG, Remke M, Rampasek L, et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017 Jun 12;31(6):737–754.e6. DOI: 10.1016/j.ccell.2017.05.005.Cavalli FMG, Remke M, Rampasek L, et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017 Jun 12;31(6):737–754.e6. DOI: 10.1016/j.ccell.2017.05.005.Sturm D, Orr BA, Toprak UH, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016 Feb 25;164(5):1060–72. DOI: 10.1016/j.cell.2016.01.015.Sturm D, Orr BA, Toprak UH, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016 Feb 25;164(5):1060–72. DOI: 10.1016/j.cell.2016.01.015.Louis DN, Aldape K, Brat DJ, et al. cIMPACTNOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification. Brain Pathol. 2017 Nov;27(6):851–852. DOI: 10.1111/bpa.12457.Louis DN, Aldape K, Brat DJ, et al. cIMPACTNOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification. Brain Pathol. 2017 Nov;27(6):851–852. DOI: 10.1111/bpa.12457.Ellison DW, Aldape KD, Capper D, et al. cIMPACTNOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol. 2020 Sep;30(5):863– 866. DOI: 10.1111/bpa.12866.Ellison DW, Aldape KD, Capper D, et al. cIMPACTNOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathol. 2020 Sep;30(5):863– 866. DOI: 10.1111/bpa.12866.Bruford EA, Braschi B, Denny P, et al. Guidelines for human gene nomenclature. Nat Genet. 2020 Aug;52(8):754-758. DOI: 10.1038/s41588-020-0669-3.Bruford EA, Braschi B, Denny P, et al. Guidelines for human gene nomenclature. Nat Genet. 2020 Aug;52(8):754-758. DOI: 10.1038/s41588-020-0669-3.Lu X, Zhang X, Deng X, et al. Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma. World Neurosurgery. 2020 Aug 1;140:e61–72. DOI: 10.1016/j.wneu.2020.04.145.Lu X, Zhang X, Deng X, et al. Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma. World Neurosurgery. 2020 Aug 1;140:e61–72. DOI: 10.1016/j.wneu.2020.04.145.Louis DN, Wesseling P, Aldape K, at al cIMPACTNOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020 Jul;30(4):844–856. DOI: 10.1111/bpa.12832.Louis DN, Wesseling P, Aldape K, at al cIMPACTNOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020 Jul;30(4):844–856. DOI: 10.1111/bpa.12832.Brat DJ, Aldape K, Colman H, et al. cIMPACTNOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathologica. 2020 Mar;139(3):603–608. DOI: 10.1007/s00401-020-02127-9.Brat DJ, Aldape K, Colman H, et al. cIMPACTNOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathologica. 2020 Mar;139(3):603–608. DOI: 10.1007/s00401-020-02127-9.Nobre L, Zapotocky M, Khan S, et al. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma. Cell Rep Med. 2020 Jun 23;1(3):100038. DOI: 10.1016/j.xcrm.2020.100038.Nobre L, Zapotocky M, Khan S, et al. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma. Cell Rep Med. 2020 Jun 23;1(3):100038. DOI: 10.1016/j.xcrm.2020.100038.Manoranjan B, Venugopal C, Bakhshinyan D, et al. Wnt activation as a therapeutic strategy in medulloblastoma. Nat Commun. 2020 Aug 28;11(1):4323. DOI: 10.1038/s41467-020-17953-4.Manoranjan B, Venugopal C, Bakhshinyan D, et al. Wnt activation as a therapeutic strategy in medulloblastoma. Nat Commun. 2020 Aug 28;11(1):4323. DOI: 10.1038/s41467-020-17953-4.Aldape K, Nejad R, Louis DN, et al. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neurooncology community. Neuro Oncol. 2017 Mar 1;19(3):336– 344. DOI: 10.1093/neuonc/now181.Aldape K, Nejad R, Louis DN, et al. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neurooncology community. Neuro Oncol. 2017 Mar 1;19(3):336– 344. DOI: 10.1093/neuonc/now181.Carpenter CD, Alnahhas I, Gonzalez J, et al. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Rev Neurother. 2019 Jul;19(7):663–677. DOI: 10.1080/14737175.2019.1621169.Carpenter CD, Alnahhas I, Gonzalez J, et al. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Rev Neurother. 2019 Jul;19(7):663–677. DOI: 10.1080/14737175.2019.1621169.Sonoda Y, Yokoo H, Tanaka S, et al. Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain Tumor Pathology. 2019 Apr;36(2):56–62. DOI: 10.1007/s10014-019-00337-y.Sonoda Y, Yokoo H, Tanaka S, et al. Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain Tumor Pathology. 2019 Apr;36(2):56–62. DOI: 10.1007/s10014-019-00337-y.Capper D, Jones DTW, Sill M. et al DNA methylation-based classification of central nervous system tumours. Nature. 2018 Mar 22;555(7697):469– 474. DOI: 10.1038/nature26000.Capper D, Jones DTW, Sill M. et al DNA methylation-based classification of central nervous system tumours. Nature. 2018 Mar 22;555(7697):469– 474. DOI: 10.1038/nature26000.Capper D, Stichel D, Sahm F, et al. Practical implementation of DNA methylation and copynumber-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018 Aug;136(2):181–210. DOI: 10.1007/s00401-018-1879-y.Capper D, Stichel D, Sahm F, et al. Practical implementation of DNA methylation and copynumber-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018 Aug;136(2):181–210. DOI: 10.1007/s00401-018-1879-y.Jaunmuktane Z, Capper D, Jones DTW, et al. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Commun. 2019 Feb 20;7(1):24. DOI: 10.1186/s40478-019-0668-8.Jaunmuktane Z, Capper D, Jones DTW, et al. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Commun. 2019 Feb 20;7(1):24. DOI: 10.1186/s40478-019-0668-8.Louis DN, Perry A, Burger P, et al. International society of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014 Sep;24(5):429–35. DOI: 10.1111/bpa.12171.Louis DN, Perry A, Burger P, et al. International society of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 2014 Sep;24(5):429–35. DOI: 10.1111/bpa.12171.Srigley JR, Judge M, Helliwell T, et al. The International Collaboration on Cancer Reporting (ICCR): a decade of progress towards global pathology standardisation and data interoperability. Histopathology. 2021 Dec;79(6):897–901. DOI: 10.1111/his.14431.Srigley JR, Judge M, Helliwell T, et al. The International Collaboration on Cancer Reporting (ICCR): a decade of progress towards global pathology standardisation and data interoperability. Histopathology. 2021 Dec;79(6):897–901. DOI: 10.1111/his.14431.

The authors declare that there are no conflicts of interest present.